For patients with stage IV triple negative breast cancer with a prolonged complete response to therapy and who are tolerating therapy well, how do you approach continuation vs cessation of therapy?
Answer from: Medical Oncologist at Academic Institution
This is a difficult question to answer. Prior studies in metastatic breast cancer that tested chemotherapy holiday showed inferior survival as compared to maintaining or attenuating systemic therapy (examples: Coates et al., PMID 3683485; Stockler et al., Breast Cancer Research and Treatment 20...
Sign in or Register to read more